A new study adds to mounting evidence that rosiglitazone — a drug used to treat Type 2 diabetes — is associated with an increased risk of major heart problems.
A new study adds to mounting evidence that rosiglitazone — a drug used to treat Type 2 diabetes — is associated with an increased risk of major heart problems.